台股 » 個股 » 生華科 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

生華科

(6492)
可現股當沖
  • 股價
    31.70
  • 漲跌
    ▼0.90
  • 漲幅
    -2.76%
  • 成交量
    63
  • 產業
    上櫃 生技醫療類股
  • 154人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
生華科 (6492)籌碼相關-永豐金-南投 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

永豐金-南投 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/04/09229.4800.0028.9021771.13%
2025/04/08131.6000.0031.6011650.61%
2025/04/07135.1000.0035.1011530.65%
2025/03/27041.4500.0040.7501510.00%
2025/03/21142.3000.0042.2511480.67%
2025/03/181442.5500.0042.50141499.34%
2025/03/17142.4500.0042.2511490.67%
2025/03/05044.8500.0044.8001500.00%
2025/02/18044.3500.0044.2501580.00%
2025/01/21041.9500.0042.7003440.00%
2025/01/1400.00242.7542.60-2382-0.52%
2025/01/07043.3000.0042.8003890.00%
2024/12/0400.00245.6545.35-2620-0.32%
2024/11/22245.3500.0045.3526690.30%
2024/11/0500.00149.5549.60-1755-0.13%
2024/11/0400.00149.6549.70-1774-0.13%
2024/10/29452.45252.7052.1027720.26%
2024/10/282.154.01157.7052.601.17560.14%
2024/10/25254.25453.3054.40-2645-0.31%
2024/10/2100.00150.3049.90-1660-0.15%
2024/10/1800.00349.9850.00-3738-0.41%
2024/10/16250.3000.0050.6029610.21%
2024/10/15150.80650.2750.10-51,055-0.47%
2024/10/11748.8900.0048.9571,0630.66%
2024/10/07151.90151.7052.1001,0520.00%
2024/09/24154.0000.0053.4011,0190.10%
2024/09/2300.00155.2054.60-11,019-0.10%
2024/09/20154.9000.0055.0011,0230.10%
2024/09/19255.1000.0053.2029950.20%
2024/09/11146.3000.0046.6511,0060.10%
2024/09/05048.9500.0047.4001,0180.00%
2024/08/23148.3500.0049.3519660.10%
2024/07/19360.43158.1058.1027350.27%
2024/07/18162.00163.0062.2006580.00%
2024/07/16156.40256.3557.20-1427-0.23%
2024/07/0500.00144.9045.65-1312-0.32%
2024/07/0400.00144.7044.85-1310-0.32%
2024/07/01147.4000.0047.1013020.33%
2024/06/2700.00447.5047.10-4296-1.35%
2024/06/26149.00348.9048.75-2288-0.69%
2024/06/21946.74346.9345.2062582.32%
2024/06/20348.00248.9847.6012500.40%
2024/06/1900.00144.5547.95-1224-0.44%
2024/06/1800.00146.0044.00-1213-0.47%
2024/06/17145.2000.0045.3511870.53%
2024/05/2800.00042.0042.3001640.00%
生華科新藥再獲孤兒藥資格 上市可獲7年市場獨賣保護期Anue鉅亨-2024/10/25
上櫃「肥貓」董監現形 台嘉碩、大宇資、穩懋、生華科為前四肥Anue鉅亨-2024/04/15
生華科治療新冠、流感等泛病毒感染新藥 將啟動二期臨床Anue鉅亨-2023/11/21
生華科 相關文章
生華科 相關影音